A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N)
No Thumbnail Available
Date
2016
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Background Familial partial lipodystrophy (FPL) is a rare genetic disorder characterized by selective lack of subcutaneous fat which is associated with insulin resistant diabetes. The Dunnigan variety (FPL2) is caused by several missense mutations in the lamin A/C (LMNA) gene, most of which are typically located in exon 8 at the codon position 482. Case report Here, we report on a Turkish family with FPL2 which is caused by a novel heterozygous missense LMNA mutation in exon 1 (D47N, c.139G > A), in the rod domain of lamins A/C. Fat distribution and metabolic features of LMNA D47N mutation were similar to typical codon 482 mutation. Metabolic abnormalities were observed as a form of insulin resistant diabetes, hypertriglyceridemia, low HDL cholesterol and hepatic steatosis. There was no evidence for neuromuscular and cardiac involvement. Conclusion Although it is previously known that alterations in the rod domain of type A lamins are involved in cardiac and neuromuscular diseases, our current observation shows that exon 1 LMNA mutations may be associated with partial lipodystrophy without any cardiac and neurological abnormalities, at least at the time of the presentation. © 2015 European Federation of Internal Medicine.
Description
Keywords
Adult , Diabetes Mellitus , Exons , Fatty Liver , Female , Heterozygote , Humans , Insulin , Insulin Resistance , Lamin Type A , Lipodystrophy, Familial Partial , Magnetic Resonance Imaging , Metformin , Mutation , high density lipoprotein cholesterol , insulin , lamin A , metformin , adult , Article , body fat distribution , case report , codon , diabetes mellitus , exon , familial partial lipodystrophy , fatty liver , female , gene mutation , heterozygote , human , hypertriglyceridemia , laboratory test , lamin A gene , lamin C gene , metabolic disorder , missense mutation , mutational analysis , neuromuscular disease , next generation sequencing , nuclear magnetic resonance spectroscopy , physical examination , ultrasound , whole body MRI , diabetes mellitus , diagnostic imaging , exon , genetics , insulin resistance , Lipodystrophy, Familial Partial , mutation , nuclear magnetic resonance imaging